How many freeze-thaw cycles will retatrutide at 20 mg/mL tolerate?

What I am working with: retatrutide · 20 mg/mL.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What is the correct sequence, and where is the step that people usually skip?

Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

Let a frozen vial reach room temperature before opening, or you condense water into it.

The part that matters: thawing at room temperature rather than in warm water reduces the interfacial stress.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Specifically, the mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Dry powder tolerates cycles far better than solution does.

edited 6 Jul 2025 by k_szabo — tightened the wording; no substantive change

It helps to be literal here: this is one of the few handling questions with a genuinely quantitative literature behind it.

A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.

Aliquot before the first freeze. That is the whole answer.

The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.

The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.

Count cycles, not degrees. The cycle is the damaging event.